guest ::
Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy(IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: analyses from the Phase 3 MYSTIC trial
; ; ; ; ; ; ; ; ; ; ; ;
In
35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung 13.–16. November 2022, Berlin
In
Oncology research and treatment 45(Suppl 3), Seiten/Artikel-Nr.:218
2022
Online
URL: https://doi.org/10.1159/000521004
Einrichtungen
External link: 
Fulltext
Dokumenttyp
Abstract/Journal Article/Contribution to a conference proceedings
Format
online, print
Sprache
English
Externe Identnummern
WOS Core Collection: WOS:000883051700351
Interne Identnummern
RWTH-CONV-249806
Datensatz-ID: 860869
Beteiligte Länder
Germany, Switzerland, UK, USA
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
Fulltext